Site Search

... let their lawmakers know that they can and must do better to prevent and treat cancer. Advocates asked lawmakers to provide better access to care by passing co-pay accumulator legislation (HB 135). Co-pay assistance does not count toward the patients’ out-of-pocket costs in a co-pay ... patient, at the right time,’ precision medicine has played a critical role in improving cancer outcomes. These asks would improve access to care and reduce the burden of cancer on Ohioans.   This year, an estimated 73,700 people in Ohio will be diagnosed with cancer and nearly 25,120 ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and made workplaces, including restaurants and bars, smoke-free. As we mark our 20th anniversary, we’re more determined than ever to ...

... patients, survivors and advocates from across the state meet with our lawmakers to remind them of the critical role they play to help foster health equity, reduce the cancer burden and save lives,” said ACS CAN California Lead Volunteer P. Kay Coleman. “This year, we’re also asking ... that have been under-resourced including communities of color, individuals with limited income, rural residents and patients receiving care in non-academic medical centers are less likely to receive recommended biomarker testing. “We urge the legislature to pass this bill to help ... California Legislative Director for ACS CAN. “Improving coverage for and access to biomarker testing across insurance types is key to reducing health inequities and improving cancer outcomes.” Senate Bill 912, which was introduced by State Sen. Monique Limón (D-Santa Barbara), aims to ...

... access to biomarker testing has not kept pace with the rate of innovation due to several factors, including lack of coverage by private health insurance and Medicaid programs for appropriate testing. The following is a statement from Brian Hummell, government relations director for ... Society Cancer Action Network (ACS CAN) in Arizona: “Biomarker testing and precision medicine are helping extend and save lives by tailoring care and treatment to a person’s individual condition. This legislation will help dismantle cost barriers and bring the promise of precision ... thanks the Arizona House for approving this legislation and urges the Senate to follow suit and also take this critical step towards reducing health inequities and improving cancer outcomes.” For more information on precision medicine, cancer biomarkers, current barriers to biomarker ...

... massive impact of medical debt by both preventing it altogether and helping families who are already facing medical debt.” The financial and health implications of medical debt for cancer patients and survivors are severe. According to the survey, an individual with cancer-related ... debt was three times more likely to be behind on recommended cancer screenings in comparison to those who have been able to pay for their care without accumulating debt. Nearly half (49%) saw their credit score decrease with 30% having difficulty qualifying for loans. Cancer-related ... report being contacted by collections agencies (66%) and to feel harassed by them (44%). “The far-reaching impacts of medical debt on people's health and well-being are especially worrisome,” added Lacasse. “As we continue to see state lawmakers across the nation step up to address the ...